2-(1,1-Dimethylethyl)-3-hydroxy-17-oxoestra-1,3,5(10)-triene-4-carboxaldehyde is an intermediate in the synthesis of 4-substituted estrone and estradiol derivatives with inhibitory activities towards steroid sulfatase as a target for therapeutic intervention of treating breast cancer.